pH-Sensitive biotinylated dendritic MRI probe to improve detection of liver tumors

MEDI 64

Md. Meser Ali, md.ali@case.edu and Mark D. Pagel, mdp12@case.edu. Department of Biomedical Engineering, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106
The extracellular pH of solid human tumors is often 0.4 units lower than normal healthy tissue. A pH-switchable MRI probe that “turns on” in lower pH conditions may improve tumor detection. For example, the relaxivity of a pH-sensitive contrast agent, GdDOTA-4AmP, rises from 3.8 to 10 mM-1s-1 on passing from pH 9.6 to 6.0. To obtain a greater increase in relaxivity, an analogue of p-SCN-Bn-DOTA-4AmP has been conjugated to the amines surface of a G5-PAMAM dendrimer, and the relaxivity of the gadolinium-loaded G5-PAMAM dendrimer increased from 11 mM-1s-1 to 24 mM-1s-1 on passing from pH 9.5 to 6.0. We have conjugated the same analogue to biotinylated G5-PAMAM dendrimer that can interact with steptavidin to passively target the dendritic MRI probe to the liver. The Biotin-G5-GdDOTA-4AmP-streptavidin conjugate is being investigated within an in vivo hepatocarcinoma woodchuck model to map liver pH and improve detection of liver tumors.